Skip to main content
. 2017 May 8;8(32):52983–52994. doi: 10.18632/oncotarget.17677

Figure 3. Combination of miR-133b and 5-FU or VCR inhibited multidrug resistant cell growth.

Figure 3

(A) The inhibition of the clone formation ability of HCT-8/5-FU and HCT-8/VCR cells. (B) The effect on the cell cycle of HCT-8/5-FU and HCT-8/VCR cells. The percentage of cells in the G1, G2 and S phases significantly altered following transfection with miR-133b. *P<0.05.